Eli Lilly (LLY) Minority Interest (2016 - 2025)
Historic Minority Interest for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $57.5 million.
- Eli Lilly's Minority Interest fell 2874.85% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.5 million, marking a year-over-year decrease of 2874.85%. This contributed to the annual value of $79.5 million for FY2024, which is 1339.87% down from last year.
- Per Eli Lilly's latest filing, its Minority Interest stood at $57.5 million for Q3 2025, which was down 2874.85% from $76.2 million recorded in Q2 2025.
- Over the past 5 years, Eli Lilly's Minority Interest peaked at $219.1 million during Q2 2021, and registered a low of $57.5 million during Q3 2025.
- In the last 5 years, Eli Lilly's Minority Interest had a median value of $91.8 million in 2023 and averaged $113.8 million.
- Its Minority Interest has fluctuated over the past 5 years, first skyrocketed by 6942.57% in 2021, then tumbled by 5139.52% in 2022.
- Eli Lilly's Minority Interest (Quarter) stood at $175.6 million in 2021, then fell by 28.47% to $125.6 million in 2022, then decreased by 26.91% to $91.8 million in 2023, then fell by 13.4% to $79.5 million in 2024, then dropped by 27.67% to $57.5 million in 2025.
- Its Minority Interest was $57.5 million in Q3 2025, compared to $76.2 million in Q2 2025 and $82.0 million in Q1 2025.